1. Home
  2. BAOS vs PPCB Comparison

BAOS vs PPCB Comparison

Compare BAOS & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baosheng Media Group Holdings

BAOS

Baosheng Media Group Holdings

HOLD

Current Price

$2.70

Market Cap

3.6M

ML Signal

HOLD

PPCB

Propanc Biopharma Inc.

N/A

Current Price

$0.22

Market Cap

3.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BAOS
PPCB
Founded
2018
2007
Country
China
Australia
Employees
N/A
N/A
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BAOS
PPCB
Price
$2.70
$0.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.8K
3.2M
Earning Date
05-08-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$860,951.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.20
N/A
52 Week Low
$1.52
$0.16
52 Week High
$8.30
$11.00

Technical Indicators

Market Signals
Indicator
BAOS
PPCB
Relative Strength Index (RSI) 44.27 33.11
Support Level $2.60 $0.16
Resistance Level $2.86 $0.24
Average True Range (ATR) 0.23 0.05
MACD -0.04 0.01
Stochastic Oscillator 14.29 23.07

Price Performance

Historical Comparison
BAOS
PPCB

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: